As of November 12, 2026, 9-OH (9-hydroxycorynantheidine) is legal to sell at retail in Idaho. Not scheduled in Idaho (Idaho Code 37-2705); no kratom act; 2026 bills H 864 and S 1282 not enacted. Controlling source: Idaho Code 37-2705 Schedule I (Title 37, ch. 27 official PDF).
Verified November 12, 2026 (hash check) · confidence: confirmedIs 9-OH Legal? Every state and federal law
Idaho does not name 9-OH, mitragynine, 7-hydroxymitragynine or kratom in its Schedule I (Idaho Code 37-2705, amended through 2026 ch. 90) or elsewhere in the Uniform Controlled Substances Act (Title 37, ch. 27); the chapter has no class entry for kratom alkaloids and no whole-plant listing for Mitragyna speciosa. Idaho has no kratom consumer protection act, so no age, labeling, registration, synthetic-alkaloid or form rule applies to a 9-OH tablet or liquid under state law. Two 2026 bills did not become law: H 864, which would have placed mitragynine, mitragynine pseudoindoxyl, 7-hydroxy mitragynine and dihydro-7-hydroxy mitragynine in Schedule I with salt and isomer words only, was referred to the House Health and Welfare Committee; S 1282, a kratom consumer protection act that would have barred products containing any semisynthetic alkaloid and sales to persons under 18, was referred to the Senate Agricultural Affairs Committee. Idaho Code 37-2702(d) directs the Board of Pharmacy to control a federally scheduled substance by temporary rule or proposed statute within thirty days of a federal final order unless it objects, so federal scheduling is not automatic, and 9-OH is not federally scheduled in any case. No Board of Pharmacy rule on kratom alkaloids appears in the Idaho Administrative Bulletin of November 4, 2026 (Vol. 26-11). Idaho has no controlled-substance analog statute. Trace 7-OH is not regulated by Idaho law today; a federal 7-OH order would reach Idaho only through board action. Local ordinances are outside this state-law row. 9-OH is not federally scheduled; federal Analogue Act and FDA exposure are interpretive.
37-2705. SCHEDULE I. (a) The controlled substances listed in this section are included in schedule I. ... (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:
Among Idaho's 6 neighbors, Nevada and Oregon are restricted; Montana, Utah and Wyoming are gray area; Washington is legal.
Open the interactive map · Every compound in Idaho · Where 9-OH is banned · Embed this map
Not federally scheduled. Not federally scheduled: absent from 21 CFR 1308.11 and every DEA kratom-alkaloid order and notice; Analogue Act exposure is interpretive Federal detail
1 instrument on file for this compound’s framework in Idaho; 4 of 4 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
031c9271fe1149e237-2702. AUTHORITY TO CONTROL. (a) The board shall administer the regulatory provisions of this act and may add substances to or delete or reschedule all substances enumerated in the schedules in section 37-2705, 37-2707, 37-2709, 37-2711, or 37-2713, Idaho Code, pursuant to the pro- 7 cedures of chapter 52, title 67, Idaho Code. In making a determination regarding a substance, the board shall consider the following: (1) The actual or relative potential for abuse; (2) The scientific evidence of its pharmacological effect, if known; (3) The state of current scientific knowledge regarding the substance; (4) The history and current pattern of abuse; (5) The scope, duration, and significance of abuse; (6) The risk to the public health; (7) The potential of the substance to produce psychic or physiological dependence liability; and (8) Whether the substance is an immediate precursor of a substance al- ready controlled under this article. (b) After considering the factors enumerated in subsection (a) of this section, the board shall make findings with respect thereto and issue a rule controlling the substance if it finds the substance has a potential for abuse. (c) If the board designates a substance as an immediate precursor, sub- stances which are precursors of the controlled precursor shall not be sub- ject to control solely because they are precursors of the controlled precur- sor. (d) If any substance is designated, rescheduled, or deleted as a con- trolled substance under federal law and notice thereof is given to the board, the board shall similarly control the substance under this act by promul- gating a temporary rule or proposing a statutory amendment, or both, within thirty (30) days from publication in the federal register of a final order designating a substance as a controlled substance or rescheduling or delet- ing a substance, unless within that thirty (30) day period, the board objects to inclusion, rescheduling, or deletion. In that case, the board shall pub- lish the reasons for objection and afford all interested parties an opportu- nity to be heard. At the conclusion of the hearing, the board shall publish its decision, which shall be final unless altered by statute. Upon publica- tion of objection to inclusion, rescheduling, or deletion under this act by the board, control under this act is stayed until the board publishes its de- cision. (e) Authority to control under this section does not extend to dis- tilled spirits, wine, malt beverages, or tobacco. [37-2702, added 1971, ch. 215, sec. 1, p. 939; am. 1972, ch. 133, sec. 2, p. 261; am. 2017, ch. 4, sec. 1, p. 5.]
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap